Our own investigations have revealed that MSC can stimulate GIST drug resistance, an effect that can be countered through the use of TGF-β inhibitors or the silencing of TGF-β receptors on GIST cells. This evidence concerns the gene TGFB1 and gastrointestinal stromal tumor.